- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, June 30, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by Healio referenced a study published online ahead of print in the October 2023 issue of The American Journal of Managed Care® (AJMC®). The study, “Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net,” evaluated the effect of an intervention based on Choosing Wisely principles on prescribing antibiotics for viral respiratory tract infections in a real-world safety-net setting.
An article by HealthcareITNews referenced a contributor article published on AJMC.com, the website of AJMC. The article, “Violence Against Healthcare Workers: A Rising Epidemic,” featured an opinion piece on how more attention needs to be given to the increasing rate of violence against workers in the health care industry.
An article from Dermatology Times® referenced an article published on AJMC.com. The article, “Experts Herald ‘Year of the JAK Inhibitor’ in Dermatology,” covered a panel at the American Academy of Dermatology 2023 that featured speakers discussing current data on the use of Janus kinase (JAK) inhibitors in dermatology.
An article from The Western Journal referenced an article published on AJMC.com. The article, “NATALEE: Ribociclib With Hormonal Therapy Cuts Recurrence Risk by 25% in Most Common Type of Breast Cancer,” focused on a trial that included patients with earlier stage breast cancer normally considered lower risk.
FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis
March 15th 2025The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the indication to include pediatric patients who are 6 years or older and positive for antiacetylcholine receptor antibodies.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More
